Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Phenytoin: an old but effective antiarrhythmic agent for the suppression of ventricular tachycardia.
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
Identification of VHY/Dusp15 as a Regulator of Oligodendrocyte Differentiation through a Systematic Genomics Approach.
Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis.
Balance control in multiple sclerosis: Correlations of trunk sway during stance and gait tests with disease severity.
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.
Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two.
Multiple sclerosis: The potassium channel KIR4.1-a potential autoantigen in MS.
Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.
Information regarding Active Biotech's candidate drug laquinimod
Self-reported Depression and Physical Activity in Adults with Mobility Impairments.
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
The effect of an AFO-shaped elastic band on drop-foot gait in patients with central neurological lesions.
Glutamate inhibition in MS: the neuroprotective properties of riluzole.
Early detection of MS treatment complication may improve survival
Accidental natalizumab administration in pregnancy in multiple sclerosis.
Anti-aquaporin-4 antibody in Chinese patients with central nervous system inflammatory demyelinating disorders.
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
CCSVI is associated with multiple sclerosis.

Pages